Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast

Summary

The purpose of this study is to establish the utility of lapatinib in the treatment of DCIS, particularly ER-negative DCIS.

Timeline

Start

2009-04

Primary completion

2010-08

Completion

2010-08

Outcome

Outcome not reported

Stopped (Enrollment): “Terminated due to low accrual”

Drugs

Indications